Product Description: Hydroxy tipelukast (Compound MN-002), the metabolite of Compound MN-001, is an orally active phenoxyalkylcarboxylic acid. Hydroxy tipelukast inhibits liver steatosis, lobular inflammation, hepatic ballooning, and hepatic scarring, and reduces liver hydroxyproline levels. Hydroxy tipelukast is promising for research of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)[1].
Formula: C29H40O7S
References: [1]Kazuko Matsuda. Method of treating liver disorders. US20140155484A1. 2015-02-24.
CAS Number: 1027597-04-1
Molecular Weight: 532.69
Research Area: Metabolic Disease; Inflammation/Immunology
Target: Drug Metabolite